In Recor Medical, Inc. v. Medtronic Ireland Manufacturing Unlimited Co., the Federal Circuit reversed a district court dismissal of patent infringement counterclaims involving renal denervation systems. The precedential opinion applied the framework set out the same day in A.L.M. v. Zydex.
